Ligand Pharmaceuticals Incorporated (LGND) Insider Trading
- $6,495,870.39
- $219,511,111.93
- July 10, 2025
- John L Higgins
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 14, 2014 | Director | 40,320 | $76.44 | Sell | $3,082,060.80 | |
| Feb. 14, 2014 | COO | 22,500 | $79.54 | Sell | $1,789,650.00 | |
| Dec. 12, 2013 | COO | 6,000 | $53.40 | Sell | $320,400.00 | |
| Dec. 6, 2013 | CFO | 6,000 | $56.08 | Sell | $336,480.00 | |
| Oct. 18, 2013 | CEO | 10,000 | $55.00 | Sell | $550,000.00 | |
| Sept. 23, 2013 | major shareholder | 359,023 | $44.50 | Sell | $15,976,523.50 | |
| Sept. 12, 2013 | Director | 160,000 | $46.78 | Sell | $7,484,800.00 | |
| Aug. 30, 2013 | VP | 28,323 | $47.54 | Sell | $1,346,475.42 | |
| Aug. 16, 2013 | VP | 14,583 | $42.63 | Sell | $621,673.29 | |
| Aug. 16, 2013 | CEO | 10,000 | $42.85 | Sell | $428,500.00 | |
| Aug. 16, 2013 | CFO | 7,500 | $42.75 | Sell | $320,625.00 | |
| June 28, 2013 | COO | 1,059 | $17.36 | Buy | $18,384.24 | |
| May 10, 2013 | VP | 4,000 | $26.66 | Sell | $106,640.00 | |
| Jan. 23, 2013 | Major Shareholder | 39,600 | $19.78 | Buy | $783,288.00 | |
| Dec. 14, 2012 | Major Shareholder | 5,386 | $18.63 | Buy | $100,341.18 | |
| Dec. 6, 2012 | Major Shareholder | 50,100 | $17.94 | Buy | $898,794.00 | |
| Dec. 5, 2012 | CEO | 2,000 | $18.03 | Buy | $36,060.00 | |
| Oct. 31, 2012 | Major Shareholder | 16,591 | $15.19 | Buy | $252,017.29 | |
| Aug. 29, 2012 | Director | 2,743 | $16.36 | Buy | $44,875.48 |
Insiders are both buying and selling Ligand Pharmaceuticals Incorporated stock.
The insider traders at Ligand Pharmaceuticals Incorporated are: Matthew W Foehr, John L Higgins, Jason Aryeh, John W Kozarich, Octavio Espinoza, Charles S Berkman, Matthew E Korenberg, Todd C Davis, Andrew Reardon, Stephen L Sabba, Bvf Partners L P/Il, John L Lamattina, David M Knott, Melanie J Herman, Bvf Partners P/Il, Nishan M Desilva, Sunil Patel, David Knott, Matthew Foehr, Charles Berkman, John Sharp, Todd Davis, John Higgins, John W. Kozarich, Melanie J. Herman, and John Lamattina
The most active insider trader at Ligand Pharmaceuticals Incorporated is Matthew W Foehr with 27 trades.
Bvf Partners P/Il has sold the most Ligand Pharmaceuticals Incorporated stock with a total value of $58,156,493.18.
Bvf Partners L P/Il has bought the most Ligand Pharmaceuticals Incorporated stock with a total value of $2,817,728.47.
The most recent insider trade for Ligand Pharmaceuticals Incorporated was on July 10, 2025.
The single biggest insider buy for Ligand Pharmaceuticals Incorporated was from Todd C Davis with a total value of $1,000,452.00 on May 9, 2025.
The single biggest insider sell for Ligand Pharmaceuticals Incorporated was from Bvf Partners P/Il with a total value of $31,214,249.00 on Feb. 20, 2014.